Institutional investors purchased a net $1.0 million shares of ILMN during the quarter ended September 2014 and now own 95.71% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 657.8 Thousand shares of Illumina Inc
MILLENNIUM MANAGEMENT LLC Bought 445.0 Thousand shares of Illumina Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 325.6 Thousand shares of Illumina Inc